Ricardo Cesar Cintra

6PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersMicrobial taxonomyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 12, 2026
Reduced LOXL3 Expression Disrupts Microtubule Acetylation and Drives TP53-Dependent Cell Fate in Glioblastoma.

Talita de Sousa Laurentino, Roseli da Silva Soares, Antônio Marcondes Lerario

|Feb 03, 2026
Targeted modulation of IGFL2-AS1 reveals its translational potential in cervical adenocarcinoma.

Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos

|Nov 13, 2025
TFAM Loss Induces Oxidative Stress and Divergent Phenotypes in Glioblastoma Metabolic Subtypes.

Stella G Cavalcante, Roseli da S Soares, Miyuki Uno

|Sep 04, 2025
<i>ROPN1</i> Gene Expression as a Prognostic and Predictive Biomarker in Aggressive Breast Cancer: Clinical Implications and Survival Association.

Ricardo Cesar Cintra, Andrés Galindo Céspedes, Olinda Maria Gamarra

|May 24, 2024
Modulation of heat shock protein expression and cytokine levels in MCF-7 cells through photodynamic therapy.

Mariela Inês Batista Dos Santos, Bruno Henrique Godoi, Newton Soares Da Silva

|Apr 02, 2021
An <i>In Silico</i> Analysis Identified FZD9 as a Potential Prognostic Biomarker in Triple-Negative Breast Cancer Patients.

Daniel Rodrigues de Bastos, Mércia Patrícia Ferreira Conceição, Ana Paula Picaro Michelli

Pageof 1